mydecine

Psychedelics biotech Mydecine Innovations Group (OTC: MYCOF) shared its condensed interim (unaudited) financial results for three months ended March 31, 2023. First quarter numbers:  Cash and cash equivalents of $7.650 (CA$10,291) as of March 31, 2023, compared to $8.199 garnered...

Psilocybin is known as the active compound in so-called “magic mushrooms”, yet most psilocybin used in clinical trials today is synthesized in laboratories without the use of biological material. As psychedelics-assisted therapy gains momentum, investors need to understand the...

The board of directors of Mydecine Innovations Group Inc. (OTCPK:MYCOF) voted in favor of completing a reverse stock split. With this action, the company will consolidate all issued and outstanding shares on a base of 1-for-50. According to Mydecine, the consolidation is expected to reduce the...

Atai Inks Largest Fundraise In Sector History With $157M Series D Psychedelics and mental health company Atai Life Sciences has raised $157 million in venture capital. The Series D funding round is being touted as the psychedelics sector’s largest to date. Christian Angermayer, who founded...

Psychedelics and biopharma company Mydecine (CSE: MYCO) (PINK: MYCOF) recently announced the successful export of 20 kilograms of dried psilocybin mushrooms from a cultivation facility in Jamaica to a facility in Canada. A World’s First: According to the Denver-based company, this represents...

The Horizons Psychedelic Stock Index ETF is now listed on Toronto’s NEO exchange under the symbol ‘PSYK.’ PSYK is the first exchange traded fund providing exposure to the burgeoning industry of medicinal psychedelics. The ETF is managed by Horizons ETFs...

Over the past year, many cannabis businesses opted to reinforce their teams by hiring beverage experts. MediPharm Labs (OTCQX: MEDIF) tapped former Nestlé Canada's President and CEO Shelley Martin to join its board of directors. Mydecine (OTC: MYCOF) and Canateq Holdings...

Ann Arbor Votes To Decriminalize Entheogenic Plants and Fungi The city of Ann Arbor in Michigan voted in favor of the decriminalization of natural psychedelics, including Psilocybe Mushrooms, Ayahuasca, the Peyote Cacti and the Iboga Plant, among others. The resolution does not legalize the...

Compass IPO Begins Trading on NASDAQ Following a NASDAQ filing earlier this month, UK-based psychedelics research company Compass Pathways began trading under the symbol CMPS on Friday. This is the first time a psychedelics company is listed on a major U.S. stock exchange. Some 7.5...

Mydecine Innovations Group (CSE: MYCO) (OTC: MYCOF) announced Wednesday that it has begun to exercise its GMP capabilities under a special license to legally produce, transfer, sell, and export pharmaceutical-grade psilocybin. The psilocybin is naturally derived from whole-mushroom extraction...

ATAI Launches Subsidiary Focused on DMT Psychedelics and biotech company ATAI Life Sciences announced the launch of Viridia Life Sciences, a wholly-owned subsidiary that will be dedicated to the study and production of the DMT molecule (N,N-Dimethyltryptamine). DMT is the active ingredient in...

PSYCHED is now weekly! As the psychedelics industry grows, so does the need for news. For this reason, our column covering the most important developments in medicinal psychedelics is now a weekly feature.  Mydecine To Acquire NeuroPharm Functional fungi and psychedelics company Mydecine...

Psyched is a bi-monthly column covering the most important developments in the industry of medicinal psychedelics. We hope you follow us periodically as we report on the growth of this exciting new industry. Silo Wellness To Go Public With Reverse Takeover Of Yukoterre Resources  Oregon-...

Psyched is a bi-monthly column covering the most important developments in the industry of medicinal psychedelics. We hope you follow us periodically as we report on the growth of this exciting new industry. New Leaf Brands Changes Name To Mydecine, Announces New HQ  Cannabis company NewLeaf...